Control of NK Cell Activation by Immune Checkpoint Molecules
AbstractThe development of cancer and chronic infections is facilitated by many subversion mechanisms, among which enhanced expression of immune checkpoints molecules, such as programmed death-1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), on exhausted T cells. Recently, immune checkpoint inhibitors have shown remarkable efficiency in the treatment of a number of cancers. However, expression of immune checkpoints on natural killer (NK) cells and its functional consequences on NK cell effector functions are much less explored. In this review, we focus on the current knowledge on expression of various immune checkpoints in NK cells, how it can alter NK cell-mediated cytotoxicity and cytokine production. Dissecting the role of these inhibitory mechanisms in NK cells is critical for the full understanding of the mode of action of immunotherapies using checkpoint inhibitors in the treatment of cancers and chronic infections. View Full-Text
Share & Cite This Article
Beldi-Ferchiou, A.; Caillat-Zucman, S. Control of NK Cell Activation by Immune Checkpoint Molecules. Int. J. Mol. Sci. 2017, 18, 2129.
Beldi-Ferchiou A, Caillat-Zucman S. Control of NK Cell Activation by Immune Checkpoint Molecules. International Journal of Molecular Sciences. 2017; 18(10):2129.Chicago/Turabian Style
Beldi-Ferchiou, Asma; Caillat-Zucman, Sophie. 2017. "Control of NK Cell Activation by Immune Checkpoint Molecules." Int. J. Mol. Sci. 18, no. 10: 2129.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.